Evidence map›Paper›PMID 41662270›Full record

ArticlePloS one2026

Patients' and relatives' perspectives on the quality of end-of-Life care in advanced cancer: From the final months to bereavement.

Moyke A J Versluis, Yvette M van der Linden, Lobke van Leeuwen-Snoeks, Marieke H J van den Beuken-van Everdingen, Mathijs P Hendriks, Ben E E M van den Borne, Dirkje Sommeijer, Jean-Paul A van Basten, Annemieke van der Padt-Pruijsten, Alexander de Graeff and 14 more

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Moyke A J VersluisResearch and development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.ORCID https://orcid.org/0000-0001-7908-294X
Yvette M van der LindenResearch and development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.ORCID https://orcid.org/0000-0002-9003-6124
Lobke van Leeuwen-SnoeksDepartment of internal medicine, Diakonessenhuis, Utrecht, the Netherlands.
Marieke H J van den Beuken-van EverdingenCentre of expertise in Palliative Care, Maastricht University Medical Centre (MUMC+), Maastricht, the Netherlands.
Mathijs P HendriksDepartment of Medical Oncology, Northwest Clinics, Alkmaar, the Netherlands.ORCID https://orcid.org/0000-0001-6687-5393
Ben E E M van den BorneDepartment of Pulmonology, Catharina Hospital, Eindhoven, the Netherlands.
Dirkje SommeijerDepartment of Internal Medicine, Flevoziekenhuis, Almere, the Netherlands.
Jean-Paul A van BastenDepartment of Urology, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands.
Annemieke van der Padt-PruijstenDepartment of Internal Medicine, Maasstad Hospital, Rotterdam, the Netherlands.
Alexander de GraeffDepartment of Medical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
Jarmo C B HuntingDepartment of Medical Oncology, St. Antonius Hospital, Utrecht, the Netherlands.
Evelien J M KuipDepartment of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
Anne S R van LindertDepartment of Pulmonology, University Medical Center Utrecht, Utrecht, the Netherlands.
Magdolen Youssef-El SoudDepartment of lung oncology, Maxima Medical Centre, Eindhoven, the Netherlands.
Martine F Thijs-VisserDepartment of Internal Medicine, Ikazia Hospital, Rotterdam, the Netherlands.
Art VreugdenhilDepartment of Medical Oncology, Maxima Medical Centre, Veldhoven, the Netherlands.
Hanneke W M van LaarhovenCancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, the Netherlands.
Wouter K de JongDepartment of Pulmonology, University Medical Centre Utrecht, Utrecht, the Netherlands.
Caroline MandigersDepartment of Internal Medicine, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands.
Lia van ZuylenCancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, the Netherlands.
Jeroen KlooverDepartment of Pulmonology, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands.
Tineke J SmildeMedical Advisor, Netherlands Health Care institute, Diemen, the Netherlands.ORCID https://orcid.org/0000-0002-4196-3765
Lonneke V van de Poll-FranseResearch and development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.
Natasja J H RaijmakersResearch and development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.ORCID https://orcid.org/0000-0002-3000-2520

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEnd-of-life care affects both patients with advanced cancer and their relatives but is often assessed from only one perspective, namely that of bereaved relatives. This study aimed to gain insight into the quality of care as experienced by patients with advanced cancer and their relatives.

methodsA total of 367 patients with stage IV cancer, 242 relatives and 163 bereaved relatives were included from a large prospective, longitudinal study (eQuiPe), which ran from November 2017 until March 2020. Patients and their relatives completed a questionnaire during the last 3 months of the patient's life. Bereaved relatives completed a questionnaire within six months after the patient's death.

resultsAt the end of life, patients reported a mean satisfaction with care score of 72/100 (SD 21), and relatives a mean score of 59/100 (SD 28) for the care they received themselves. Continuity with care, the extent to which the care received from different healthcare professionals was coordinated, was associated with higher satisfaction with care in patients (β 2.1, 95% CI 1.6-2.6). Bereaved relatives reported that most patients died peacefully (87%) and at home (73%). Most bereaved relatives (66%) were contacted by a healthcare professional after the patient's death, but over half were not informed about grief (52%) or the available options for bereavement support (58%), with about 20% reporting they would have appreciated this.

conclusionsQuality of end-of-life care was generally perceived as good. This study highlights the importance of good continuity of care as it is associated with higher satisfaction with care in patients. Also, one-fifth of the bereaved relatives reported that they had not been informed about bereavement care despite desiring it, which emphasizes the need for better care for relatives before and after the patient's death.

Indexed as

BereavementFamilyNeoplasmsQuality of Health CareTerminal CareAdultAgedAged, 80 and overFemaleHumansLongitudinal StudiesMaleMiddle AgedPatient SatisfactionProspective StudiesSurveys and Questionnaires

Identifiers

PMID41662270
PMCPMC12885308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.